AGER and hepatocellular carcinoma: In summary, we identified two risk-associated polymorphisms (rs1045411 and rs2070600) and more importantly a joint impact of seven polymorphisms from the HMGB1/RAGE axis in susceptibility to hepatocellular carcinoma.